BIOCRYST PHARMACEUTICALS, INC. Earnings Per Share (Basic)
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Earnings Per Share (Basic) of $0.31 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was $0.31, a 1450.00% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$2.98.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-12-31 was $1.17.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was $0.06.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was $1.26.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was -$0.43.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$1.18.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$1.33.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.31 10-Q · filed 2026-08-05 | -$2.59 10-Q · filed 2026-08-05 | -$1.69 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.68 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | -$2.98 10-Q · filed 2026-05-06 | -$2.10 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$2.09 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$2.10 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | $1.17 derived: net income ÷ weighted average shares · filed 2026-04-23 | $1.23 derived: net income ÷ weighted average shares · filed 2026-04-23 | $1.25 derived: net income ÷ weighted average shares · filed 2026-08-05 | $1.26 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.06 10-Q · filed 2025-11-04 | $0.09 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.09 10-Q · filed 2025-11-04 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | $0.02 10-Q · filed 2026-08-05 | $0.02 10-Q · filed 2026-08-05 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2024-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.43 10-K · filed 2026-02-26 |
| 2024-09-30 | -$0.07 10-Q · filed 2025-11-04 | -$0.13 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.30 10-Q · filed 2025-11-04 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2024-06-30 | -$0.06 10-Q · filed 2025-08-05 | -$0.23 10-Q · filed 2025-08-05 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2024-03-31 | -$0.17 10-Q · filed 2025-05-06 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.06 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2023-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.90 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.18 10-K · filed 2026-02-26 |
| 2023-09-30 | -$0.19 10-Q · filed 2024-11-05 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-11-05 | -$0.87 10-Q · filed 2024-11-05 | -$1.25 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2023-06-30 | -$0.40 10-Q · filed 2024-08-06 | -$0.68 10-Q · filed 2024-08-06 | -$1.06 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2023-03-31 | -$0.28 10-Q · filed 2024-05-07 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.21 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2022-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.33 10-K · filed 2025-02-25 |
| 2022-09-30 | -$0.23 10-Q · filed 2023-11-08 | -$0.55 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.95 10-Q · filed 2023-11-08 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2022-06-30 | -$0.32 10-Q · filed 2023-08-07 | -$0.72 10-Q · filed 2023-08-07 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.15 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2022-03-31 | -$0.40 10-Q · filed 2023-05-08 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-04-23 |
| 2021-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-04-23 | -$1.03 10-K · filed 2024-02-27 |
| 2021-09-30 | -$0.33 10-Q · filed 2022-11-04 | -$0.57 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$0.93 10-Q · filed 2022-11-04 | |
| 2021-06-30 | -$0.24 10-Q · filed 2022-08-05 | -$0.60 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | -$0.36 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | -$1.09 10-K · filed 2023-02-27 | |||
| 2016-06-30 | -$0.22 10-Q · filed 2016-08-08 | -$0.53 10-Q · filed 2016-08-08 | ||
| 2015-12-31 | -$0.25 10-K · filed 2017-02-27 | |||
| 2015-09-30 | -$0.20 10-K · filed 2017-02-27 | |||
| 2015-06-30 | $0.07 10-K · filed 2017-02-27 | -$0.14 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | -$0.21 10-K · filed 2017-02-27 | |||
| 2014-06-30 | -$0.23 10-Q · filed 2015-08-07 | -$0.40 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |